🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 9 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/04/2017 10,40 10,72 10,18 10,63 +2,02% 5,19% 6.400
17/04/2017 10,55 10,66 10,28 10,42 -1,33% 3,60% 11.000
13/04/2017 11,36 11,36 10,53 10,56 -0,38% 7,31% 17.400
12/04/2017 10,46 10,72 10,24 10,60 +0,47% 4,62% 9.000
11/04/2017 10,66 11,00 9,93 10,55 -2,04% 10,04% 22.800
10/04/2017 10,57 11,25 10,34 10,77 +4,06% 8,61% 14.100
07/04/2017 11,34 11,39 10,31 10,35 -9,05% 9,53% 36.600
06/04/2017 12,58 12,97 11,01 11,38 -8,08% 15,58% 40.200
05/04/2017 12,25 13,43 12,12 12,38 +2,82% 10,65% 33.600
04/04/2017 12,23 12,82 11,94 12,04 -0,66% 7,20% 46.900
03/04/2017 12,89 13,20 12,02 12,12 -5,39% 9,15% 28.500
31/03/2017 13,37 13,80 12,12 12,81 -4,47% 12,57% 71.100
30/03/2017 13,06 13,64 12,82 13,41 -1,11% 6,28% 76.000
29/03/2017 14,14 14,14 13,50 13,56 -2,16% 4,53% 7.200
28/03/2017 13,79 14,16 13,70 13,86 +1,09% 3,34% 52.900
27/03/2017 12,52 13,99 12,52 13,71 +3,71% 11,74% 60.600
24/03/2017 13,01 13,68 13,01 13,22 +0,53% 5,15% 7.400
23/03/2017 12,32 13,46 12,10 13,15 +5,28% 11,04% 16.500
22/03/2017 12,32 12,60 12,12 12,49 +1,22% 3,90% 24.300
21/03/2017 12,93 12,93 12,15 12,34 -5,37% 6,03% 27.600
20/03/2017 13,10 13,95 12,58 13,04 -0,38% 10,46% 35.800
17/03/2017 12,62 13,61 12,37 13,09 +2,35% 9,83% 46.200
16/03/2017 12,80 13,03 12,32 12,79 +0,63% 5,51% 42.500
15/03/2017 13,24 13,24 12,30 12,71 -1,63% 7,10% 25.400
14/03/2017 13,57 13,86 12,40 12,92 -8,04% 10,76% 50.100
13/03/2017 13,71 14,17 13,71 14,05 +2,41% 3,36% 19.400
10/03/2017 13,54 13,80 13,20 13,72 +1,33% 4,43% 28.800
09/03/2017 13,88 13,90 13,50 13,54 -0,37% 2,88% 10.100
08/03/2017 13,57 14,77 13,18 13,59 +0,89% 11,72% 88.100
07/03/2017 13,68 13,69 13,22 13,47 -1,46% 3,44% 19.300